People · Operator
Named in public records as an officer, director or promoter · active 2015–2022 · Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Iagnosis, Inc. | — | Other Technology | Series A | $14.2M | $57.4M | 2015 |
| Infectious Disease Connect, Inc. | — | Other Health Care | Series A | $7.4M | $13.9M | 2022 |
David A. Zynn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David A. Zynn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Phillips | 1 | 14 |
| Joel Krikston | 1 | 4 |
| Brenton Burns | 1 | 3 |
| Peter N. Stephans | 1 | 2 |
| Riaan Erwee | 1 | 1 |
| Tami Minnier | 1 | 1 |
| Rima Abdel-Massih | 1 | 1 |
| Brenton A. Burns | 1 | 1 |
| Erwee A. Riaan | 1 | 1 |
| Tami A. Minnier | 1 | 1 |
| Mark P. Seraly | 1 | 1 |
| Joel A. Krikston | 1 | 1 |
| Lawrence E. Eakin | 1 | 1 |
| Lawrence E. Eakin, Jr. | 1 | 1 |
| Michael E. Rossi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.